Related Experiment Video

Updated: Mar 21, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

7.5K

Eplerenone does not limit ischemia-reperfusion injury in human myocardial tissue

T N A Daniëlle van den Berg1, H A van Swieten2, J C Vos3

  • 1Department of Pharmacology and Toxicology, Radboud university medical center, Nijmegen, The Netherlands; Department of Internal Medicine, Radboud university medical center, Nijmegen, The Netherlands.

International Journal of Cardiology
|May 6, 2016
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CardioprotectionContractile functionEplerenoneHuman atrial tissueIschemia-reperfusion injuryMineralocorticoid receptor antagonists

More Related Videos

Model of Ischemia and Reperfusion Injury in Rabbits06:11

Model of Ischemia and Reperfusion Injury in Rabbits

Published on: November 3, 2023

2.0K
Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

924

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K